模拟加价提高了2025年的收益和收入预测,使股票价格提高了1.29美元。 Simulations Plus raises 2025 earnings and revenue forecasts, boosting stock price by $1.29.

模拟+更新了2025年财政年度指南,预测每股收入在1.07至1.20美元之间,收入在9 000万至9 300万美元之间。 Simulations Plus updated its 2025 fiscal year guidance, projecting earnings per share (EPS) between $1.07 and $1.20, and revenue between $90 million and $93 million. 这一更新显示,股份增加了1.29美元,增至30.39美元。 This update sees shares rise by $1.29 to $30.39. 该公司最近超过EPS共识估计值0.02美元,比去年同期收入增长19.9%。 The company recently surpassed EPS consensus estimates by $0.02, showing a 19.9% revenue increase from the same period last year. Walter S. Woltosz董事出售了20,000股,仍拥有300多万股。 Director Walter S. Woltosz sold 20,000 shares, still owning over 3 million shares. 模拟+提供AI驱动药物发现软件。 Simulations Plus provides AI-driven drug discovery software.